Título: Doutora
E-mail: [email protected]
Lattes: http://lattes.cnpq.br/1272564477655719
Orcid: ID  0000-0002-7585-4348 – https://orcid.org/0000-0002-7585-4348
Scopus: ID 23570766000 – https://www.scopus.com/authid/detail.uri?authorId=23570766000
Google scholar: ID 3GC6H1cAAAAJ&hl – https://scholar.google.com.br/citations?user=3GC6H1cAAAAJ&hl=pt-BR&oi=ao
Research ID:I-5962-2013 – https://publons.com/researcher/2619609/nadia-e-aikawa/

Lines of research:

Aspects related to biological therapy in patients with pediatric rheumatological diseases and complications in pediatric rheumatological diseases.

Summary

The research is conducted at the Pediatric Rheumatology outpatient clinic of the HCFMUSP Children’s Institute and the HCFMUSP Rheumatology Program and at the Center for the Dispensation of High-Complexity Medications (CEDMAC), the mission of which is to provide care and conduct studies related to biological therapies in patients with rheumatological diseases.

Relevant articles:

  1. Esteves GCX, Gormezano NWS, Pereira OL, Kern D, Silva CA, Pereira RMR, Kozu KT, Bonfá E, Aikawa NE. Distinct clinical correlates of immune thrombocytopenic purpura at diagnosis of childhood-onset and adult SLE. Mod Rheumatol. 2018 Jul;28(4):649-653. doi: 10.1080/14397595.2017.1386836.
  2. Brunelli JB, Bonfiglioli KR, Silva CA, Kozu KT, Goldenstein-Schainberg C, Bonfa E, Aikawa NE. Latent tuberculosis infection screening in juvenile idiopathic arthritis patients preceding anti-TNF therapy in a tuberculosis high-risk country. Rev Bras Reumatol Engl Ed. 2017 Sep – Oct;57(5):392-396. doi: 10.1016/j.rbre.2016.11.004.
  3. Brunelli JB, Schmidt AR, Sallum AME, Goldenstein-Schainberg C, Bonfá E, Silva CA, Aikawa NE. High rate of serious infection in juvenile idiopathic arthritis patients under biologic therapy in a real-life setting. Mod Rheumatol. 2018;28(2):264-270. doi: 10.1080/14397595.2017.1349059.
  4. Aikawa NE, França IL, Ribeiro AC, Sallum AM, Bonfa E, Silva CA. Short and long-term immunogenicity and safety following the 23-valent polysaccharide pneumococcal vaccine in juvenile idiopathic arthritis patients under conventional DMARDs with or without anti-TNF therapy. Vaccine. 2015 Jan 29;33(5):604-9. doi: 10.1016/j.vaccine.2014.12.030.
  5. Aikawa NE, Campos LM, Silva CA, Carvalho JF, Saad CG, Trudes G, Duarte A, Miraglia JL, Timenetsky Mdo C, Viana VS, França IL, Bonfa E, Pereira RM. Glucocorticoid: major factor for reduced immunogenicity of 2009 influenza A (H1N1) vaccine in patients with juvenile autoimmune rheumatic disease. J Rheumatol. 2012 Jan;39(1):167-73. doi: 10.3899/jrheum.110721.